Chronic Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia [Phase 3]
Phase 3 trial in previously untreated chronic lymphocytic leukemia compares fludarabine and cyclophosphamide with or without rituximab; resu…
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders [Phase 2]
Phase 2 clinical trial evaluating the combination of Campath-1H (alemtuzumab) and rituximab for CD52- and CD20-positive refractory or relaps…
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma [Phase 2]
Phase 2 clinical trial update on using a conditioning regimen of fludarabine and melphalan for patients with chronic lymphocytic leukemia, l…
-
CLINICAL_TRIALS trial_result · 2011-02-02Clinical Trial Update: SPC2996 in Chronic Lymphocytic Leukaemia [Phase 1, Phase 2]
Clinical trial update reporting completion of a Phase 1/2 study of SPC2996 in chronic lymphocytic leukemia.
-
CLINICAL_TRIALS trial_result · 2011-01-13Clinical Trial Update: Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL) [Phase 2]
Phase 2 trial of alemtuzumab combined with fludarabine in relapsed/refractory B-cell chronic lymphocytic leukemia completed with posted resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-12-30Clinical Trial Update: Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial evaluating Rituximab and Fludarabine followed by alemtuzumab (CAMPATH-1H) in chronic lymphocytic leukemia and small lymphocyti…
-
CLINICAL_TRIALS trial_result · 2010-12-20Clinical Trial Update: A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax). [Phase 1]
Phase 1 study evaluating how ketoconazole affects the metabolism of navitoclax (ABT-263) in patients with lymphoma, chronic lymphocytic leuk…
-
CLINICAL_TRIALS trial_result · 2010-10-07Clinical Trial Update: Assess the Oral Bioavailability of New ABT-263 Formulations [Phase 1]
Phase 1 pharmacokinetic study assessing oral bioavailability of new ABT-263 formulations.
-
CLINICAL_TRIALS trial_result · 2010-09-22Clinical Trial Update: Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia [Phase 1, Phase 2]
A Phase 1/2 chemotherapy study for chronic lymphocytic leukemia has completed, according to the clinical trial update.
-
CLINICAL_TRIALS trial_result · 2010-09-15Clinical Trial Update: High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia [Phase 1]
This Phase 1 clinical trial evaluates high-dose chemotherapy with total-body irradiation followed by peripheral stem cell transplantation in…
-
CLINICAL_TRIALS trial_result · 2010-09-14Clinical Trial Update: Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 clinical trial investigates combining fresh frozen plasma with Rituximab (Mabthera) in patients with advanced refractory chronic l…
-
CLINICAL_TRIALS trial_result · 2010-09-10Clinical Trial Update: Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Phase 2, multi-center trial evaluating the combination of lenalidomide (Revlimid) and rituximab as first-line therapy for chronic lymphocyti…
-
CLINICAL_TRIALS trial_result · 2010-08-13Clinical Trial Update: Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 clinical trial evaluating AT-101 in combination with Rituximab for chronic lymphocytic leukemia has completed, assessing safety an…
-
CLINICAL_TRIALS trial_result · 2010-07-30Clinical Trial Update: Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia [Phase 1, Phase 2]
Phase 1/2 trial evaluating donor natural killer cell infusion with Rituximab, Aldesleukin, and chemotherapy in relapsed non-Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of BL22 immunotoxin in patients with refractory chronic lymphocytic leukemia, prolymphocytic leukemia, and non-Hodgkin lymphom…
-
CLINICAL_TRIALS trial_result · 2010-06-02Clinical Trial Update: The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL) [Phase 1, Phase 2]
A clinical trial update on milatuzumab for refractory chronic lymphocytic leukemia across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2010-05-05Clinical Trial Update: Study of Immune Response Modifier in the Treatment of Hematologic Malignancies [Phase 2]
Phase 2 trial of an immune response modifier in hematologic malignancies has terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2010-03-31Clinical Trial Update: Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia [Phase 1]
A Phase 1 clinical trial of forodesine in relapsed B-cell chronic lymphocytic leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-03-08Clinical Trial Update: Phase 1, Dose-Escalation, Pharmacodynamic Study of IV CNF1010 in ZAP-70 Positive CLL [Phase 1]
Phase 1 dose-escalation pharmacodynamic study of CNF1010 in ZAP-70 positive chronic lymphocytic leukemia; the study is terminated.
-
CLINICAL_TRIALS trial_result · 2010-02-24Clinical Trial Update: Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial evaluating the combination of bryostatin and fludarabine in patients with chronic lymphocytic leukemia or relapsed indolent no…
-
CLINICAL_TRIALS trial_result · 2010-02-23Clinical Trial Update: High-dose Methylprednisolone and Rituximab in High Risk B-CLL [Phase 2]
Phase 2 trial evaluating high-dose methylprednisolone with rituximab in high-risk chronic lymphocytic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-16Clinical Trial Update: A Single-arm Phase II Study of Alemtuzumab in Combination With High-dose Methylprednisolone in CLL Patients With p53 Deletion [Phase 2]
This report summarizes the completion of a single-arm Phase II study evaluating alemtuzumab in combination with high-dose methylprednisolone…
-
CLINICAL_TRIALS trial_result · 2009-08-18Clinical Trial Update: T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation [Phase 3]
A Phase 3 trial investigating T-cell and B-cell depletion in allogeneic peripheral blood stem cell transplantation has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) [Phase 2]
Phase 2 clinical trial evaluating treosulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation, focusing on saf…
-
CLINICAL_TRIALS trial_result · 2009-06-25Clinical Trial Update: Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL) [Phase 2]
This is an interventional Phase 2 trial evaluating a pentostatin, cyclophosphamide, and rituximab regimen for indolent B-cell non-Hodgkin ly…